Literature DB >> 27779665

Effect of zinc deficiency on mouse renal interstitial fibrosis in diabetic nephropathy.

Xiuli Zhang1, Dan Liang2, Xu Lian3, Zhi-Hong Chi1, Xuemei Wang1, Yue Zhao1, Zhang Ping4.   

Abstract

There is emerging evidence that tubulointerstitial fibrosis is the final common pathway of the majority of chronic progressive renal diseases, including diabetic nephropathy (DN). Zinc, an essential dietary element, has been suggested to be important for a number of protein functions during fibrosis in vivo and in vitro. However, the effect of zinc deficiency (ZnD) on renal interstitial fibrosis in DN remains unclear. The present study investigated the effect and the underlying mechanisms of ZnD on renal interstitial fibrosis during DN using an streptozotocin‑induced model of diabetes with immunofluorescence staining and western blot analysis. The present study identified that dietary zinc restriction significantly decreased zinc concentrations in the plasma and mouse kidney. ZnD enhanced albuminuria and extracellular matrix protein expression, associated with diabetic renal interstitial fibrosis by activation of renal interstitial fibroblasts and regulation of the expression of fibrosis‑associated factors, which may be mediated by the activation of fibroblasts via the TGF‑β/Smad signaling pathway. The data indicates that ZnD serves an important role in the pathogenic mechanisms of renal interstitial fibrosis during the development of DN.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27779665     DOI: 10.3892/mmr.2016.5870

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  5 in total

Review 1.  Role of Zinc in Diabetic Kidney Disease.

Authors:  Guido Gembillo; Luca Visconti; Alfio Edoardo Giuffrida; Vincenzo Labbozzetta; Luigi Peritore; Antonella Lipari; Vincenzo Calabrese; Giorgina Barbara Piccoli; Massimo Torreggiani; Rossella Siligato; Domenico Santoro
Journal:  Nutrients       Date:  2022-03-24       Impact factor: 5.717

2.  Effect of zinc deficiency on chronic kidney disease progression and effect modification by hypoalbuminemia.

Authors:  Atsuyuki Tokuyama; Eiichiro Kanda; Seiji Itano; Megumi Kondo; Yoshihisa Wada; Hiroyuki Kadoya; Kengo Kidokoro; Hajime Nagasu; Tamaki Sasaki; Naoki Kashihara
Journal:  PLoS One       Date:  2021-05-11       Impact factor: 3.240

3.  Influence of zinc levels and Nrf2 expression in the clinical and pathological changes in patients with diabetic nephropathy.

Authors:  Ping Nie; Yan Lou; Xue Bai; Yuexin Zhu; Qiaoyan Guo; Ping Luo; Weiguang Zhang; Bing Li
Journal:  Nutr Diabetes       Date:  2022-08-06       Impact factor: 4.725

Review 4.  Nutraceutical Prevention of Diabetic Complications-Focus on Dicarbonyl and Oxidative Stress.

Authors:  Mark F McCarty; James J DiNicolantonio; James H O'Keefe
Journal:  Curr Issues Mol Biol       Date:  2022-09-18       Impact factor: 2.976

5.  Alleviation of diabetic nephropathy by zinc oxide nanoparticles in streptozotocin-induced type 1 diabetes in rats.

Authors:  Ghada Alomari; Bahaa Al-Trad; Salehhuddin Hamdan; Alaa A A Aljabali; Mazhar Salim Al Zoubi; Khalid Al-Batanyeh; Janti Qar; Gregory J Eaton; Almuthanna K Alkaraki; Walhan Alshaer; Saja Haifawi; Khairunadwa Jemon; Dinesh Kumar Chellappan; Kamal Dua; Murtaza M Tambuwala
Journal:  IET Nanobiotechnol       Date:  2021-03-10       Impact factor: 2.050

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.